Systemically, isolated PAX6 mutations have been associated with reports of type 1 and 2 diabetes (25, 26, 28), obesity (28), brain anatomical and neurodevelopmental anomalies, neurobehavioral disorders, and autism spectrum disorder (29–35). This evidence concerns the gene PAX6 and obesity due to melanocortin 4 receptor deficiency.